INCYTE revenue breakdown overview

INCYTE revenue for the last year amounted to 3.35 B EUR, the most of which — 3.35 B EUR — came from its highest performing source at the moment, Proprietary Therapeutics, the year earlier bringing 3.17 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought INCYTE 3.17 B EUR, and the year before that — 2.99 B EUR.